Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |